Health Care: Drugs

Albany Molecular Research Inc. (AMRI: NASDAQ)

$11.08 0.13 | 1.19%
05/17/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 226.69M 207.64M 198.07M 196.42M
Cost of Sales 150.73M 150.32M 135.21M 121.61M
Gross Operating Profit 75.95M 57.33M 62.85M 74.81M
Selling, General, and Administrative Expenses 44.05M 44.76M 55.68M 41.78M
Research & Development 906.00K 7.94M 11.09M 14.55M
Operating Income before D & A (EBITDA) 31.00M 4.64M -3.91M 18.48M
Depreciation & Amortization 17.33M 18.16M 17.46M 17.13M
Interest Income 9.00K 131.00K 452.00K 646.00K
Other Income - Net -130.00K 77.00K -962.00K -545.00K
Special Income / Charges -8.33M -21.34M -47.69M -22.90M
Total Income Before Interest Expenses (EBIT) 582.00K -35.92M -72.67M -21.78M
Interest Expense 463.00K 714.00K 175.00K 270.00K
Pre-Tax Income 119.00K -36.64M -72.84M -22.05M
Income Taxes 3.90M -4.34M -9.97M -5.36M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -3.78M 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -3.78M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -3.78M -32.30M -62.87M -16.70M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 9.19M 22.61M 50.78M 23.23M
Preferred Dividends
Net Income Available To Common -3.78M 0.00 0.00 0.00
Basic EPS from Continuing Ops. -0.12 -1.08 -2.05 -0.54
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.12 -1.08 -2.05 -0.54
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.12 -1.08 -2.05 -0.54
Basic Normalized Net Income/Share 0.29 n.a. n.a. n.a.
EPS fr Continuing Ops. -0.12 -1.08 -2.05 -0.54
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.12 -1.08 -2.05 -0.54
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.12 -1.08 -2.05 -0.54
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 0.29 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AMRI

View All

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases

Partner Headlines for AMRI

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter